<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34101196</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-7580</ISSN><JournalIssue CitedMedium="Internet"><Volume>241</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of anatomy</Title><ISOAbbreviation>J Anat</ISOAbbreviation></Journal><ArticleTitle>Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS).</ArticleTitle><Pagination><StartPage>1089</StartPage><EndPage>1107</EndPage><MedlinePgn>1089-1107</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/joa.13463</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a motor neuron disease with an extremely heterogeneous clinical and genetic phenotype. In our efforts to find therapies for ALS, the scientific community has developed a plethora of mouse models, each with their own benefits and drawbacks. The peripheral nervous system, specifically the neuromuscular junction (NMJ), is known to be affected in ALS patients and shows marked dysfunction across mouse models. Evidence of pathology at the NMJ includes denervated NMJs, changes in endplate size and loss of terminal Schwann cells. This review compares the temporal disease progression with severity of disease at the NMJ in mouse models with the most commonly mutated genes in ALS patients (SOD1, C9ORF72, TARDBP and FUS). Despite variability, early NMJ dysfunction seems to be a common factor in models with SOD1, TARDBP and FUS mutations, while C9ORF72 models do not appear to follow the same pattern of pathology. Further work into determining the timing of NMJ pathology, particularly in newer ALS mouse models, will confirm its pivotal role in ALS pathogenesis and therefore highlight the NMJ as a potential therapeutic target.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Journal of Anatomy published by John Wiley &amp;amp; Sons Ltd on behalf of Anatomical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alhindi</LastName><ForeName>Abrar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boehm</LastName><ForeName>Ines</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-9343-0944</Identifier><AffiliationInfo><Affiliation>Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaytow</LastName><ForeName>Helena</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2257-7620</Identifier><AffiliationInfo><Affiliation>Edinburgh Medical School, Biomedical Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Anatomical Society</Agency><Country/></Grant><Grant><Agency>My Name'5 Doddie Foundation</Agency><Country/></Grant><Grant><Agency>King Abdulaziz University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Anat</MedlineTA><NlmUniqueID>0137162</NlmUniqueID><ISSNLinking>0021-8782</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">NMJ</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">denervation</Keyword><Keyword MajorTopicYN="N">dying-back</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>8</Day><Hour>12</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34101196</ArticleId><ArticleId IdType="pmc">PMC9558162</ArticleId><ArticleId IdType="doi">10.1111/joa.13463</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alhindi, A. , Boehm, I. , Forsythe, R.O. , Miller, J. , Skipworth, R.J.E. , Simpson, H. et al. (2021) Terminal Schwann cells at the human neuromuscular junction. Brain Communications, 3, fcab081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8093923</ArticleId><ArticleId IdType="pubmed">33977269</ArticleId></ArticleIdList></Reference><Reference><Citation>Apel, P.J. , Ma, J. , Callahan, M. , Northam, C.N. , Alton, T.B. , Sonntag, W.E. et al. (2010) Effect of locally delivered IGF&#x2010;1 on nerve regeneration during aging: an experimental study in rats. Muscle and Nerve, 41(3), 335&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3045758</ArticleId><ArticleId IdType="pubmed">19802878</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour, D. , Tremblay, E. , Martineau, &#xc9;. , Julien, J.P. &amp; Robitaille, R. (2015) Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model. Journal of Neuroscience, 35(2), 688&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6605374</ArticleId><ArticleId IdType="pubmed">25589763</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold, E.S. , Ling, S.C. , Huelga, S.C. , Lagier&#x2010;Tourenne, C. , Polymenidou, M. , Ditsworth, D. et al. (2013) ALS&#x2010;linked TDP&#x2010;43 mutations produce aberrant RNA splicing and adult&#x2010;onset motor neuron disease without aggregation or loss of nuclear TDP&#x2010;43. Proceedings of the National Academy of Sciences of the United States of America, 110(8), E736&#x2013;E745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahia El Idrissi, N. , Bosch, S. , Ramaglia, V. , Aronica, E. , Baas, F. &amp; Troost, D. (2016) Complement activation at the motor end&#x2010;plates in amyotrophic lateral sclerosis. Journal of Neuroinflammation, 13(1), 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823861</ArticleId><ArticleId IdType="pubmed">27056040</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland, L.G. , Sahai, E. , Kelly, G. , Golding, M. , Greensmith, L. &amp; Schiavo, G. (2010) Deficits in axonal transport precede ALS symptoms in vivo. Proceedings of the National Academy of Sciences of the United States of America, 107(47), 20523&#x2013;20528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2996651</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornskov, E.K. , Dekker, N.P. , Norris, F.H. &amp; Stuart, M.E. (1975) End&#x2010;plate morphology in amyotrophic lateral sclerosis. Archives of Neurology, 32(10), 711&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">1180738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornskov, E.K. , Norris, F.H. &amp; Mower&#x2010;Kuby, J. (1984) Quantitative axon terminal and end&#x2010;plate morphology in amyotrophic lateral sclerosis. Archives of Neurology, 41(5), 527&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">6721721</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehm, I. , Miller, J. , Wishart, T.M. , Wigmore, S.J. , Skipworth, R.J.E. , Jones, R.A. et al. (2020) Neuromuscular junctions are stable in patients with cancer cachexia. Journal of Clinical Investigation, 130(3), 1461&#x2013;1465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269586</ArticleId><ArticleId IdType="pubmed">31794435</ArticleId></ArticleIdList></Reference><Reference><Citation>Boido, M. , De Amicis, E. , Valsecchi, V. , Trevisan, M. , Ala, U. , Ruegg, M.A. et al. (2018) Increasing agrin function antagonizes muscle atrophy and motor impairment in spinal muscular atrophy. Frontiers in Cellular Neuroscience, 12, 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5797594</ArticleId><ArticleId IdType="pubmed">29440993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bros&#x2010;Facer, V. , Krull, D. , Taylor, A. , Dick, J.R.T. , Bates, S.A. , Cleveland, M.S. et al. (2014) Treatment with an antibody directed against Nogo&#x2010;A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis. Human Molecular Genetics, 23(16), 4187&#x2013;4200.</Citation><ArticleIdList><ArticleId IdType="pubmed">24667415</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau, G. , Bauch&#xe9;, S. , Gonzalez de Aguilar, J.L. , Brochier, G. , Mandjee, N. , Tanguy, M.&#x2010;L. et al. (2015) Endplate denervation correlates with Nogo&#x2010;A muscle expression in amyotrophic lateral sclerosis patients. Annals of Clinical and Translational Neurology, 2(4), 362&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco, D.I. , Bahr, B.A. , Seburn, K.L. &amp; Pinter, M.J. (2016) Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease. Experimental Neurology, 278(1), 116&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4788963</ArticleId><ArticleId IdType="pubmed">26853136</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco, D.I. , Seburn, K.L. &amp; Pinter, M.J. (2016) Altered terminal Schwann cell morphology precedes denervation in SOD1 mice. Experimental Neurology, 275(10), 172&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4768763</ArticleId><ArticleId IdType="pubmed">26416261</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand, K.K. , Lee, K.M. , Lee, J.D. , Qiu, H. , Willis, E.F. , Lavidis, N.A. et al. (2018) Defects in synaptic transmission at the neuromuscular junction precedes motor deficits in a TDP&#x2010;43Q331K transgenic mouse model of amyotrophic lateral sclerosis. The FASEB Journal, 32, 2676&#x2013;2689.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295857</ArticleId></ArticleIdList></Reference><Reference><Citation>Charcot, J.M. (1865) Sclerose des cordons lateraux de lamoelle epiniere chez une femme hysterique atteinnte de contracture permanente des quatre membres. Bull Soc Med (Paris), 24&#x2013;35.</Citation></Reference><Reference><Citation>Chiu, A.Y. , Zhai, P. , Dal Canto, M.C. , Peters, T.M. , Kwon, Y.W. , Prattis, S.M. et al. (1995) Age&#x2010;dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Molecular and Cellular Neurosciences, 6, 349&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">8846004</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark, J.A. , Southam, K.A. , Blizzard, C.A. , King, A.E. &amp; Dickson, T.C. (2016) Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Journal of Chemical Neuroanatomy, 76, 35&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman, M. (2005) Axon degeneration mechanisms: commonality amid diversity. Nature Reviews Neuroscience, 6(11), 889&#x2013;898.</Citation><ArticleIdList><ArticleId IdType="pubmed">16224497</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia, P. , Vourc'h, P. , Blasco, H. , Couratier, P. , Dangoumau, A. , Bellance, R. et al. (2018) Phenotypic and genotypic studies of ALS cases in ALS&#x2010;SMA families. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(5&#x2013;6), 432&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pubmed">29493298</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne, A.N. , Lorenzini, I. , Chou, C.C. , Torvund, M. , Rogers, R.S. , Starr, A. et al. (2017) Post&#x2010;transcriptional inhibition of Hsc70&#x2010;4/HSPA8 expression leads to synaptic vesicle cycling defects in multiple models of ALS. Cell Reports, 21(1), 110&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5679478</ArticleId><ArticleId IdType="pubmed">28978466</ArticleId></ArticleIdList></Reference><Reference><Citation>Day, N.C. , Wood, S.J. , Ince, P.G. , Volsen, S.G. , Smith, W. , Slater, C.R. et al. (1997) Differential localization of voltage&#x2010;dependent calcium channel &#x3b1;1 subunits at the human and rat neuromuscular junction. The Journal of Neuroscience, 17(16), 6226&#x2013;6235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568369</ArticleId><ArticleId IdType="pubmed">9236233</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus&#x2010;Hernandez, M. , Mackenzie, I. , Boeve, B. , Boxer, A. , Baker, M. , Rutherford, N. et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p&#x2010;linked FTD and ALS. Neuron, 72(2), 245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng, H. , Gao, K. &amp; Jankovic, J. (2014) The role of FUS gene variants in neurodegenerative diseases. Nature Reviews Neurology, 10(6), 337&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">24840975</ArticleId></ArticleIdList></Reference><Reference><Citation>Devoy, A. , Kalmar, B. , Stewart, M. , Park, H. , Burke, B. , Noy, S.J. et al. (2017) Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in &#x201c;FUSDelta14&#x201d; knockin mice. Brain, 140(11), 2797&#x2013;2805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5841203</ArticleId><ArticleId IdType="pubmed">29053787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditsworth, D. , Maldonado, M. , McAlonis&#x2010;Downes, M. , Sun, S. , Seelman, A. , Drenner, K. et al. (2017) Mutant TDP&#x2010;43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis. Acta Neuropathologica, 133(6), 907&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5427168</ArticleId><ArticleId IdType="pubmed">28357566</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, W. , Zhang, L.I. , Sun, C. , Gao, X. , Guan, F. , Li, J. et al. (2020) Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats. Animal Models and Experimental Medicine, 3(3), 237&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529333</ArticleId><ArticleId IdType="pubmed">33024945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebstein, S.Y. , Yagudayeva, I. &amp; Shneider, N.A. (2019) Mutant TDP&#x2010;43 causes early&#x2010;stage dose&#x2010;dependent motor neuron degeneration in a TARDBP knockin mouse model of ALS. Cell Reports, 26(2), 364&#x2013;373.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">30625319</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeili, M.A. , Panahi, M. , Yadav, S. , Hennings, L. &amp; Kiaei, M. (2013) Premature death of TDP&#x2010;43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. International Journal of Experimental Pathology, 94(1), 56&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575874</ArticleId><ArticleId IdType="pubmed">23317354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzi, S.A. , Larivi&#xe8;re, R. , Urushitani, M. &amp; Julien, J.P. (2010) Neuronal over&#x2010;expression of chromogranin A accelerates disease onset in a mouse model of ALS. Journal of Neurochemistry, 115(5), 1102&#x2013;1111.</Citation><ArticleIdList><ArticleId IdType="pubmed">20807312</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini, C. , Bassell, G.J. &amp; Rossoll, W. (2012) The ALS disease protein TDP&#x2010;43 is actively transported in motor neuron axons and regulates axon outgrowth. Human Molecular Genetics, 21(16), 3703&#x2013;3718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406762</ArticleId><ArticleId IdType="pubmed">22641816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer, L.R. , Culver, D.G. , Tennant, P. , Davis, A.A. , Wang, M. , Castellano&#x2010;Sanchez, A. et al. (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Experimental Neurology, 185(2), 232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga, N. , Menon, P. , &#xd6;zdinler, P.H. , Kiernan, M.C. &amp; Vucic, S. (2016) Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nature Reviews Neurology, 12(11), 651&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillingwater, T.H. , Thomson, D. , Mack, T.G.A. , Soffin, E.M. , Mattison, R.J. , Coleman, M.P. et al. (2002) Age&#x2010;dependent synapse withdrawal at axotomised neuromuscular junctions in Wlds mutant and Ube4b/Nmnat transgenic mice. Journal of Physiology, 543(3), 739&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2290540</ArticleId><ArticleId IdType="pubmed">12231635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon, D. , Dafinca, R. , Scaber, J. , Alegre&#x2010;Abarrategui, J. , Farrimond, L. , Scott, C. et al. (2019) Single&#x2010;copy expression of an amyotrophic lateral sclerosis&#x2010;linked TDP&#x2010;43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction. Neurobiology of Disease, 121, 148&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">30290270</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould, T.W. , Buss, R.R. , Vinsant, S. , Prevette, D. , Sun, W. , Knudson, C.M. et al. (2006) Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. Journal of Neuroscience, 26(34), 8774&#x2013;8786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6674380</ArticleId><ArticleId IdType="pubmed">16928866</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Y. , Wang, Q. , Zhang, K. , An, T. , Shi, P. , Li, Z. et al. (2012) HO&#x2010;1 induction in motor cortex and intestinal dysfunction in TDP&#x2010;43 A315T transgenic mice. Brain Research, 1460, 88&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">22578468</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney, M. , Pu, H. , Chiu, A. , Dal Canto, M. , Polchow, C. , Alexander, D. et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264(5166), 1772&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman, O. , Al&#x2010;Chalabi, A. , Chio, A. , Corr, E.M. , Logroscino, G. , Robberecht, W. et al. (2017) Amyotrophic lateral sclerosis. Nature Reviews Disease Primers, 3, 17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison, J.M. &amp; Rafuse, V.F. (2020) Muscle fiber&#x2010;type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1G93A mice. Neurobiology of Disease, 145, 105052.</Citation><ArticleIdList><ArticleId IdType="pubmed">32827689</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus, J. , Putman, C.T. &amp; Gordon, T. (2007) Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease, 28(2), 154&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Herranz&#x2010;Martin, S. , Chandran, J. , Lewis, K. , Mulcahy, P. , Higginbottom, A. , Walker, C. et al. (2017) Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat&#x2010;length&#x2010;dependent neuropathology and behavioural deficits. Disease Models and Mechanisms, 10(7), 859&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536911</ArticleId><ArticleId IdType="pubmed">28550099</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt, C. , Kirby, J. , Highley, J.R. , Hartley, J.A. , Hibberd, R. , Hollinger, H.C. et al. (2010) Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis. Archives of Neurology, 67(4), 455&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">20385912</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;rnberg, H. &amp; Holt, C. (2013) RNA&#x2010;binding proteins and translational regulation in axons and growth cones. Frontiers in Neuroscience, 7, 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661996</ArticleId><ArticleId IdType="pubmed">23734093</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard, J.F. (2003) Chapter 3 Structure and function of the neuromuscular junction. In: Stalberg, E. (Ed.) Handbook of Clinical Neurophysiology. 2. Elsevier B.V, pp. 27&#x2013;46.</Citation></Reference><Reference><Citation>Huang, G. , Lee, X. , Bian, Y. , Shao, Z. , Sheng, G. , Pepinsky, R.B. et al. (2013) Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis. Cell Death and Disease, 4(10), 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3824687</ArticleId><ArticleId IdType="pubmed">24113175</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, S.L. , Wu, L.S. , Lee, M. , Chang, C.W. , Cheng, W.C. , Fang, Y.S. et al. (2020) A robust TDP&#x2010;43 knock&#x2010;in mouse model of ALS. Acta Neuropathologica Communications, 8(1), 1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6975031</ArticleId><ArticleId IdType="pubmed">31964415</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi, Y. , Katsuno, M. , Niwa, J.I. , Takagi, S. , Ishigaki, S. , Ikenaka, K. , et al. (2013) Loss of TDP&#x2010;43 causes age&#x2010;dependent progressive motor neuron degeneration. Brain, 136(5), 1371&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pubmed">23449777</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokic, N. , Gonzalez de Aguilar, J.L. , Dimou, L. , Lin, S. , Fergani, A. , Ruegg, M.A. et al. (2006) The neurite outgrowth inhibitor Nogo&#x2010;A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Reports, 7(11), 1162&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1679784</ArticleId><ArticleId IdType="pubmed">17039253</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokic, N. , Gonzalez de Aguilar, J.L. , Pradat, P.F. , Dupuis, L. , Echaniz&#x2010;Laguna, A. , Muller, A. et al. (2005) Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Annals of Neurology, 57(4), 553&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">15786457</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones, R.A. , Harrison, C. , Eaton, S.L. , Llavero Hurtado, M. , Graham, L.C. , Alkhammash, L. et al. (2017) Cellular and molecular anatomy of the human neuromuscular junction. Cell Reports, 21(9), 2348&#x2013;2356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5723673</ArticleId><ArticleId IdType="pubmed">29186674</ArticleId></ArticleIdList></Reference><Reference><Citation>Juneja, T. , Pericak&#x2010;Vance, M.A. , Laing, N.G. , Dave, S. &amp; Siddique, T. (1997) Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with Glu100gly and Ala4val mutations in Cu,Zn superoxide dismutase. Neurology, 48(1), 55&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">9008494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kankel, M.W. , Sen, A. , Lu, L. , Theodorou, M. , Dimlich, D.N. , McCampbell, A. et al. (2020) Amyotrophic lateral sclerosis modifiers in drosophila reveal the phospholipase d pathway as a potential therapeutic target. Genetics, 215(3), 747&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337071</ArticleId><ArticleId IdType="pubmed">32345615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli, K. , Pratt, G.A. , Vu, A.Q. , Hutt, K.R. , Martinez, F.J. , Sundararaman, B. et al. (2016) Distinct and shared functions of ALS&#x2010;associated proteins TDP&#x2010;43, FUS and TAF15 revealed by multisystem analyses. Nature Communications, 7, 12143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, G. , Gautier, O. , Tassoni&#x2010;Tsuchida, E. , Ma, X.R. &amp; Gitler, A.D. (2020) ALS genetics: gains, losses, and implications for future therapies. Neuron, 108(5), 822&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong, L. , Wang, X. , Choe, D.W. , Polley, M. , Burnett, B.G. , Bosch&#x2010;Marce, M. et al. (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. Journal of Neuroscience, 29(3), 842&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2746673</ArticleId><ArticleId IdType="pubmed">19158308</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers, M. , Blokhuis, A.M. , Westeneng, H.J. , Terpstra, M.L. , Zundel, C.A.C. , Vieira De S&#xe1;, R. et al. (2015) C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Annals of Neurology, 78(3), 426&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer, B.C. , Schuck, T. , Wheeler, J.M. , Robinson, L.C. , Trojanowski, J.Q. , Lee, V.M.Y. et al. (2010) Loss of Murine TDP&#x2010;43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathologica, 119(4), 409&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2880609</ArticleId><ArticleId IdType="pubmed">20198480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriz, J. , Nguyen, M.D. &amp; Julien, J.P. (2002) Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease, 10(3), 268&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">12270689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier&#x2010;Tourenne, C. , Polymenidou, M. , Hutt, K.R. , Vu, A.Q. , Baughn, M. , Huelga, S.C. et al. (2012) Divergent roles of ALS&#x2010;linked proteins FUS/TLS and TDP&#x2010;43 intersect in processing long pre&#x2010;mRNAs. Nature Neuroscience, 15(11), 1488&#x2013;1497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai, J.D. &amp; Ichida, J.K. (2019) C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis. Neuroscience Letters, 713, 134523.</Citation><ArticleIdList><ArticleId IdType="pubmed">31568865</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H.F. &amp; Wu, Z.Y. (2016) Genotype&#x2010;phenotype correlations of amyotrophic lateral sclerosis. Translational Neurodegeneration, 5(1), 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4738789</ArticleId><ArticleId IdType="pubmed">26843957</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, C. , Shao, Q. , Zhang, W. , Yang, M. , Chang, Q. , Chen, R. et al. (2019) Smcr8 deficiency disrupts axonal transport&#x2010;dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models. Human Molecular Genetics, 28(23), 3940&#x2013;3953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282195</ArticleId><ArticleId IdType="pubmed">31625563</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, J.X. , Br&#xe4;nnstr&#xf6;m, T. , Andersen, P.M. &amp; Pedrosa&#x2010;Domell&#xf6;f, F. (2013) Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors. PLoS One, 8(2), e57473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582511</ArticleId><ArticleId IdType="pubmed">23468993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. , Pattamatta, A. , Zu, T. , Reid, T. , Bardhi, O. , Borchelt, D. et al. (2016) C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron, 90(3), 521&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau, &#xc9;. , Arbour, D. , Vall&#xe9;e, J. &amp; Robitaille, R. (2020) Properties of glial cell at the neuromuscular junction are incompatible with synaptic repair in the SOD1G37R ALS mouse model. Journal of Neuroscience, 40(40), 7759&#x2013;7777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7531543</ArticleId><ArticleId IdType="pubmed">32859714</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau, &#xc9;. , Di Polo, A. , Vande Velde, C. &amp; Robitaille, R. (2018) Dynamic neuromuscular remodeling precedes motor&#x2010;unit loss in a mouse model of ALS. eLife, 7, 1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234026</ArticleId><ArticleId IdType="pubmed">30320556</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau, &#xc9;. , Di Polo, A. , Velde, C.V. &amp; Robitaille, R. (2020) Sex&#x2010;specific differences in motor&#x2010;unit remodeling in a mouse model of ALS. eNeuro, 7(1), 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7044502</ArticleId><ArticleId IdType="pubmed">32033983</ArticleId></ArticleIdList></Reference><Reference><Citation>Maselli, R.A. , Wollman, R.L. , Leung, C. , Distad, B. , Palombi, S. , Richman, D.P. et al. (1993) Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle and Nerve, 16, 1193&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pubmed">8105377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mech, A.M. , Brown, A.L. , Schiavo, G. &amp; Sleigh, J.N. (2020) Morphological variability is greater at developing than mature mouse neuromuscular junctions. Journal of Anatomy, 237, 603&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7495279</ArticleId><ArticleId IdType="pubmed">32533580</ArticleId></ArticleIdList></Reference><Reference><Citation>Meininger, V. , Genge, A. , van den Berg, L.H. , Robberecht, W. , Ludolph, A. , Chio, A. et al. (2017) Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double&#x2010;blind, placebo&#x2010;controlled, phase 2 trial. The Lancet Neurology, 16(3), 208&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">28139349</ArticleId></ArticleIdList></Reference><Reference><Citation>Minty, G. , Hoppen, A. , Boehm, I. , Alhindi, A. , Gibb, L. , Potter, E. et al. (2020) ANMJ&#x2010;morph: a simple macro for rapid analysis of neuromuscular junction morphology. Royal Society Open Science, 7(4), 200128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211862</ArticleId><ArticleId IdType="pubmed">32431902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, J.C. , Constable, R. , So, E. , Vance, C. , Scotter, E. , Glover, L. et al. (2015) Wild type human TDP&#x2010;43 potentiates ALS&#x2010;linked mutant TDP&#x2010;43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathologica Communications, 3, 36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4479086</ArticleId><ArticleId IdType="pubmed">26108367</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, J.C. , McGoldrick, P. , Vance, C. , Hortobagyi, T. , Sreedharan, J. , Rogelj, B. et al. (2013) Overexpression of human wild&#x2010;type FUS causes progressive motor neuron degeneration in an age&#x2010; and dose&#x2010;dependent fashion. Acta Neuropathologica, 125(2), 273&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mora, J.S. , Genge, A. , Chio, A. , Estol, C.J. , Chaverri, D. , Hern&#xe1;ndez, M. et al. (2020) Masitinib as an add&#x2010;on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(1&#x2013;2), 5&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31280619</ArticleId></ArticleIdList></Reference><Reference><Citation>Narai, H. , Manabe, Y. , Nagai, M. , Nagano, I. , Ohta, Y. , Murakami, T. et al. (2009) Early detachment of neuromuscular junction proteins in ALS mice with SODG93A mutation. Neurology International, 1(1), 16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093225</ArticleId><ArticleId IdType="pubmed">21577353</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan, R.K. , Mangelsdorf, M. , Panwar, A. , Butler, T.J. , Noakes, P.G. &amp; Wallace, R.H. (2013) Identification of RNA bound to the TDP&#x2010;43 ribonucleoprotein complex in the adult mouse brain. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(4), 252&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">23134510</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, M. , Rademakers, R. , Roeber, S. , Baker, M. , Kretzschmar, H.A. &amp; MacKenzie, I.R.A. (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain, 132(11), 2922&#x2013;2931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, M. , Sampathu, D.M. , Kwong, L.K. , Truax, A.C. , Micsenyi, M.C. , Chou, T.T. et al. (2006) Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314(5796), 130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen, J. , Comley, L.H. &amp; Hedlund, E. (2017) Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathologica, 133(6), 863&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke, J. , Bogdanik, L. , Muhammad, A. , Gendron, T. , Kim, K. , Austin, A. et al. (2015) C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron, 88(5), 892&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou, S.H. , Wu, F. , Harrich, D. , Garc&#xed;a&#x2010;Mart&#xed;nez, L.F. &amp; Gaynor, R.B. (1995) Cloning and characterization of a novel cellular protein, TDP&#x2010;43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. Journal of Virology, 69(6), 3584&#x2013;3596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma, E. , Reyes&#x2010;Ruiz, J.M. , Lopergolo, D. , Roseti, C. , Bertollini, C. , Ruffolo, G. et al. (2016) Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy. Proceedings of the National Academy of Sciences of the United States of America, 113(11), 3060&#x2013;3065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4801305</ArticleId><ArticleId IdType="pubmed">26929355</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez&#x2010;Garc&#xed;a, M.J. &amp; Burden, S.J. (2012) Increasing MuSK activity delays denervation and improves motor function in ALS mice. Cell Reports, 2(3), 497&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3462266</ArticleId><ArticleId IdType="pubmed">22939980</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, O. , Cabrera, G. , Tran, H. , Gendron, T. , McKeon, J. , Metterville, J. et al. (2015) Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice. Neuron, 88(5), 902&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828340</ArticleId><ArticleId IdType="pubmed">26637797</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfohl, S.R. , Halicek, M.T. &amp; Mitchell, C.S. (2015) Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: a meta&#x2010;analysis. Journal of Neuromuscular Diseases, 2(2), 137&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4652798</ArticleId><ArticleId IdType="pubmed">26594635</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli, G. , Demestre, M. , Zuko, A. , Been, M. , Higelin, J. , Dieterl&#xe9;, S. et al. (2019) FUS&#x2010;mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nature Neuroscience, 22(11), 1793&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858880</ArticleId><ArticleId IdType="pubmed">31591561</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad, A. , Bharathi, V. , Sivalingam, V. , Girdhar, A. &amp; Patel, B.K. (2019) Molecular mechanisms of TDP&#x2010;43 misfolding and pathology in amyotrophic lateral sclerosis. Frontiers in Molecular Neuroscience, 12, 1&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton, A.E. , Chi&#xf2;, A. &amp; Traynor, B.J. (2014) State of play in amyotrophic lateral sclerosis genetics. Nature Neuroscience, 17(1), 17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton, A. , Majounie, E. , Waite, A. , Sim&#xf3;n&#x2010;S&#xe1;nchez, J. , Rollinson, S. , Gibbs, J. et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21&#x2010;linked ALS&#x2010;FTD. Neuron, 72(2), 257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemslagh, F.W. , van der Toorn, E.C. , Verhagen, R.F.M. , Maas, A. , Bosman, L.W.J. , Hukema, R.K. et al. (2021) Inducible expression of human C9ORF72 36x G4C2 hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice. Disease Models and Mechanisms, 14, dmm.044842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903916</ArticleId><ArticleId IdType="pubmed">33431483</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha, M.C. , Pousinha, P.A. , Correia, A.M. , Sebasti&#xe3;o, A.M. &amp; Ribeiro, J.A. (2013) Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS One, 8(9), 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman, W. &amp; Gomes, E.R. (2018) Nuclear positioning in skeletal muscle. Seminars in Cell and Developmental Biology, 82, 51&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">29241690</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen, D.R. , Siddique, T. , Patterson, D. , Figlewicz, D.A. , Sapp, P. , Hentati, A. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362(6415), 59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff, R.L. (2003) Neurophysiology of the neuromuscular junction: overview. Annals of the New York Academy of Sciences, 998(1), 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">14592857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakowski, S.A. , Schuyler, A.D. &amp; Feldman, E.L. (2009) Insulin&#x2010;like growth factor&#x2010;I for the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 10(2), 63&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3211070</ArticleId><ArticleId IdType="pubmed">18608100</ArticleId></ArticleIdList></Reference><Reference><Citation>Santosa, K.B. , Keane, A.M. , Jablonka&#x2010;Shariff, A. , Vannucci, B. &amp; Snyder&#x2010;Warwick, A.K. (2018) Clinical relevance of terminal Schwann cells: an overlooked component of the neuromuscular junction. Journal of Neuroscience Research, 96(7), 1125&#x2013;1135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6292684</ArticleId><ArticleId IdType="pubmed">29536564</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic&#x2010;Zahirovic, J. , Sendscheid, O. , El Oussini, H. , Jambeau, M. , Sun, Y. , Mersmann, S. et al. (2016) Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. The EMBO Journal, 35(10), 1077&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer, A.M. , Sanes, J.R. &amp; Lichtman, J.W. (2005) A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. Journal of Comparative Neurology, 490(3), 209&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">16082680</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan, X. , Chiang, P.M. , Price, D.L. &amp; Wong, P.C. (2010) Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP&#x2010;43 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 107(37), 16325&#x2013;16330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2941282</ArticleId><ArticleId IdType="pubmed">20736350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, A. , Lyashchenko, A.K. , Lu, L. , Nasrabady, S.E. , Elmaleh, M. , Mendelsohn, M. et al. (2016) ALS&#x2010;associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nature Communications, 7, 10465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw, M.P. , Higginbottom, A. , McGown, A. , Castelli, L.M. , James, E. , Hautbergue, G.M. et al. (2018) Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Acta Neuropathologica Communications, 6(1), 125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240957</ArticleId><ArticleId IdType="pubmed">30454072</ArticleId></ArticleIdList></Reference><Reference><Citation>So, E. , Mitchell, J.C. , Memmi, C. , Chennell, G. , Vizcay&#x2010;Barrena, G. , Allison, L. et al. (2018) Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice. Human Molecular Genetics, 27(3), 463&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886082</ArticleId><ArticleId IdType="pubmed">29194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson, E.J. , Windbank, A.J. , Mandrekar, J.N. , Bamlet, W.R. , Appel, S.H. , Armon, C. et al. (2008) Subcutaneous IGF&#x2010;1 is not beneficial in 2&#x2010;year ALS trial. Neurology, 71(22), 1770&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2617770</ArticleId><ArticleId IdType="pubmed">19029516</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup, V. , Phaneuf, D. , Bareil, C. , Robertson, J. , Rouleau, G.A. , Kriz, J. &amp; et al. (2011) Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP&#x2010;43 genomic fragments. Brain, 134(9), 2610&#x2013;2626.</Citation><ArticleIdList><ArticleId IdType="pubmed">21752789</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallon, C. , Russell, K.A. , Sakhalkar, S. , Andrapallayal, N. &amp; Farah, M.H. (2016) Length&#x2010;dependent axo&#x2010;terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice. Neuroscience, 312, 179&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4691388</ArticleId><ArticleId IdType="pubmed">26592719</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay, E. , Martineau, &#xc9;. &amp; Robitaille, R. (2017) Opposite synaptic alterations at the neuromuscular junction in an ALS mouse model: when motor units matter. Journal of Neuroscience, 37(37), 8901&#x2013;8918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6596800</ArticleId><ArticleId IdType="pubmed">28821658</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujihata, M. , Hazama, R. , Yoshimura, T. , Satoh, A. , Mori, M. &amp; Nagataki, S. (1984) The motor end&#x2010;plate fine structure and ultrastructural localization of acetylcholine receptors in amyotrophic lateral sclerosis. Muscle and Nerve, 7(3), 243&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">6708970</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner, B.J. , Lopes, E.C. &amp; Cheema, S.S. (2003) Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neuroscience Letters, 350(2), 132&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">12972170</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant, S. , Mansfield, C. , Jimenez&#x2010;Moreno, R. , Moore, V.D.G. , Yoshikawa, M. , Hampton, T.G. et al. (2013) Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part II, results and discussion. Brain and Behavior, 3(4), 431&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3869683</ArticleId><ArticleId IdType="pubmed">24381813</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, A.K. , Spiller, K.J. , Ge, G. , Zheng, A. , Xu, Y. , Zhou, M. et al. (2015) Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP&#x2010;43. Acta Neuropathologica, 130(5), 643&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J. , Ho, W.Y. , Lim, K. , Feng, J. , Tucker&#x2010;Kellogg, G. , Nave, K.A. et al. (2018) Cell&#x2010;autonomous requirement of TDP&#x2010;43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination. Proceedings of the National Academy of Sciences of the United States of America, 115(46), E10941&#x2013;E10950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6243235</ArticleId><ArticleId IdType="pubmed">30373824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W. , Li, L.I. , Lin, W.L. , Dickson, D.W. , Petrucelli, L. , Zhang, T. et al. (2013) The ALS disease&#x2010;associated mutant TDP&#x2010;43 impairs mitochondrial dynamics and function in motor neurons. Human Molecular Genetics, 22(23), 4706&#x2013;4719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>White, M.A. , Kim, E. , Duffy, A. , Adalbert, R. , Phillips, B.U. , Peters, O.M. et al. (2018) TDP&#x2010;43 gains function due to perturbed autoregulation in a Tardbp knock&#x2010;in mouse model of ALS&#x2010;FTD. Nature Neuroscience, 21(4), 552&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson, M.G. , Finelli, M.J. , Sleigh, J.N. , Reddington, A. , Gordon, D. , Talbot, K. et al. (2019) Neuronal over&#x2010;expression of Oxr1 is protective against ALS&#x2010;associated mutant TDP&#x2010;43 mislocalisation in motor neurons and neuromuscular defects in vivo. Human Molecular Genetics, 28(21), 3584&#x2013;3599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6927465</ArticleId><ArticleId IdType="pubmed">31642482</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, P.C. , Pardo, C.A. , Borchelt, D.R. , Lee, M.K. , Copeland, N.G. , Jenkins, N.A. et al. (1995) An adverse property of a familial ALS&#x2010;linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14(6), 1105&#x2013;1116.</Citation><ArticleIdList><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood, S.J. , Slater, C.R. (2001) Safety factor at the neuromuscular junction. Progress in Neurobiology, 64, 393&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">11275359</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara, T. , Ishii, T. , Iwata, M. &amp; Nomoto, M. (1998) Ultrastructural and histochemical study of the motor end plates of the intrinsic laryngeal muscles in amyotrophic lateral sclerosis. Ultrastructural Pathology, 22(2), 121&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">9615380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Z. , Pinto, A.M. , Wan, L. , Wang, W. , Berg, M.G. , Oliva, I. et al. (2013) Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy. Proceedings of the National Academy of Sciences of the United States of America, 110(48), 19348&#x2013;19353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845193</ArticleId><ArticleId IdType="pubmed">24191055</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou, Z.Y. , Zhou, Z.R. , Che, C.H. , Liu, C.Y. , He, R.L. &amp; Huang, H.P. (2017) Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta&#x2010;analysis. Journal of Neurology, Neurosurgery and Psychiatry, 88(7), 540&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>